46 results on '"Schwäble, Joachim"'
Search Results
2. Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation.
3. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units
4. Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy
5. One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
6. First human leucocyte antigen (HLA) response and safety evaluation of fibrous demineralized bone matrix in a critical size femoral defect model of the Sprague Dawley rat
7. The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARα and regulates differentiation of hematopoietic cells
8. First Human Leucocyte Antigen (HLA) Response and Safety Evaluation of Fibrous Demineralized Bone Matrix in a Critical Size Femoral Defect Model of the Sprague-Dawley Rat
9. Treatment Options in Hemophilia
10. Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
11. High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
12. Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions
13. High efficiency gene correction in hematopoietic cells by donor-template-free CRISPR/Cas9 genome editing
14. High Efficiency Gene Correction in Hematopoietic Cells By Template-Free Crispr/Cas9 Genome Editing
15. Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions
16. Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing
17. CD133-targeted Gene Transfer Into Long-term Repopulating Hematopoietic Stem Cells
18. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
19. From bench to bedside : preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease
20. Gentherapie der septischen Granulomatose : Chancen und Risiken ; der Weg zur erfolgreichen Therapie einer angeborenen Immundefizienz
21. From Bench to Bedside: Preclinical Evaluation of a Self-Inactivating Gammaretroviral Vector for the Gene Therapy of X-linked Chronic Granulomatous Disease
22. Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing
23. Gentherapie der septischen Granulomatose: Chancen und Risiken. Der Weg zur erfolgreichen Therapie einer angeborenen Immundefizienz
24. Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma
25. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
26. Activation mechanisms of STAT5 by oncogenic Flt3-ITD
27. Flt3-dependent transformation by inactivating c-Cbl mutations in AML
28. Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors
29. Wnt signaling regulates transendothelial migration of monocytes
30. The molecular pathogenesis of acute myeloid leukemia
31. Constitutive Activation of Akt by Flt3 Internal Tandem Duplications Is Necessary for Increased Survival, Proliferation, and Myeloid Transformation
32. AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
33. Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction
34. RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
35. Identification of Metastasis-Associated Receptor Tyrosine Kinases in Non–Small Cell Lung Cancer
36. High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets
37. Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
38. The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARaand regulates differentiation of hematopoietic cells.
39. RGS2is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
40. Activation Mechanisms of STAT5 by Oncogenic Flt3-ITD.
41. Constitutive Activation of Akt and mTOR by Flt3 Internal Tandem Duplications Mediates Myeloid Leukemogenesis and Can Be Inhibited by Rapamycin.
42. Flt3 Internal Tandem Duplications Cooperate with Wnt Signaling in Leukemic Signal Transduction.
43. Selective red blood cell depletion by apheresis in sheep causes severe normovolemic anemia.
44. High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing.
45. [Gene therapy for septic granulomatosis: risks and opportunities. The road to successful treatment of congenital immunodeficiency].
46. Flt3 receptor tyrosine kinase as a drug target in leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.